Senseonics Holdings, Inc. rose 2.68% in premarket trading. The company held a special call to discuss the Eversense 365 Commercial Update, which may have positively influenced investor sentiment. Additionally, news about Tandem Diabetes Care's mobile app approval and its global offerings expansion could have indirectly impacted Senseonics Holdings, Inc. as both companies operate in the diabetes technology sector.
Comments
No comments yet